Indriani Silvia

1 ta ish

Universitas Swadaya Gunung Jati

1. Pembrolizumab in PD-L1-positive Advanced Non-Small Cell Lung Carcinoma: A Meta-Analysis Survival Benefits and Immune-related Toxicity Events Patterns

   Alendra Chakramurty, Adetya Rahma Dinni, Indriani Silvia +2

   Maqola20252 iqtibos

   ABIABI:AkademIndex/2026.other.817186